Health Secretary Matt Hancock has been urged to immediately review the epilepsy medicine supply chain, after ongoing problems for patients who are struggling to obtain their treatments.
Health secretary Matt Hancock responded to an urgent question tabled by Conservative MP Sir Mike Penning yesterday, following the seizure of £4,000-worth of medical cannabis products at Sou
US Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Catalyst Pharma’s rare disease drug Firdapse, which is at the heart of a
Roche has finally won NICE backing for the use of Perjeta (pertuzumab) to prevent early-stage HER2-positive breast cancer from recurring after surgery, at the third attempt.
Managing patients’ expectations of CAR-T therapies is proving to be a huge challenge from when selection decisions are made, through the treatment process and when they are recovering at ho
There is increasing recognition that skin clearance scores may not be enough to win over patients and doctors when it comes to the highly competitive market for psoriasis drugs, even though
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.